261 related articles for article (PubMed ID: 30871542)
1. The effects of two vitamin D regimens on ulcerative colitis activity index, quality of life and oxidant/anti-oxidant status.
Karimi S; Tabataba-Vakili S; Yari Z; Alborzi F; Hedayati M; Ebrahimi-Daryani N; Hekmatdoost A
Nutr J; 2019 Mar; 18(1):16. PubMed ID: 30871542
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory biomarkers response to two dosages of vitamin D supplementation in patients with ulcerative colitis: A randomized, double-blind, placebo-controlled pilot study.
Karimi S; Tabataba-Vakili S; Ebrahimi-Daryani N; Yari Z; Karimi A; Hedayati M; Hekmatdoost A
Clin Nutr ESPEN; 2020 Apr; 36():76-81. PubMed ID: 32220372
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol Supplementation and Oxidative/Anti-Oxidative Status in Patients with Ulcerative Colitis: A Randomized, Double-Blind, Placebo-controlled Pilot Study.
Samsamikor M; Daryani NE; Asl PR; Hekmatdoost A
Arch Med Res; 2016 May; 47(4):304-9. PubMed ID: 27664491
[TBL] [Abstract][Full Text] [Related]
4. Higher vitamin D serum concentration increases health related quality of life in patients with inflammatory bowel diseases.
Hlavaty T; Krajcovicova A; Koller T; Toth J; Nevidanska M; Huorka M; Payer J
World J Gastroenterol; 2014 Nov; 20(42):15787-96. PubMed ID: 25400464
[TBL] [Abstract][Full Text] [Related]
5. Anti-Inflammatory Effects of Resveratrol in Patients with Ulcerative Colitis: A Randomized, Double-Blind, Placebo-controlled Pilot Study.
Samsami-Kor M; Daryani NE; Asl PR; Hekmatdoost A
Arch Med Res; 2015 May; 46(4):280-5. PubMed ID: 26002728
[TBL] [Abstract][Full Text] [Related]
6. Oral Nano Vitamin D Supplementation Reduces Disease Activity in Ulcerative Colitis: A Double-Blind Randomized Parallel Group Placebo-controlled Trial.
Ahamed Z R; Dutta U; Sharma V; Prasad KK; Popli P; Kalsi D; Vaishnavi C; Arora S; Kochhar R
J Clin Gastroenterol; 2019; 53(10):e409-e415. PubMed ID: 31356558
[TBL] [Abstract][Full Text] [Related]
7. A randomized controlled trial on the coloprotective effect of coenzyme Q10 on immune-inflammatory cytokines, oxidative status, antimicrobial peptides, and microRNA-146a expression in patients with mild-to-moderate ulcerative colitis.
Farsi F; Ebrahimi-Daryani N; Golab F; Akbari A; Janani L; Karimi MY; Irandoost P; Alamdari NM; Agah S; Vafa M
Eur J Nutr; 2021 Sep; 60(6):3397-3410. PubMed ID: 33620550
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D suppresses proangiogenic factors in patients with ulcerative colitis: A randomized double blind placebo controlled clinical trial.
Emami MR; Sharifi A; Yaseri M; Derakhshanian H; Hosseinzadeh-Attar MJ
Complement Ther Clin Pract; 2020 May; 39():101086. PubMed ID: 31957666
[TBL] [Abstract][Full Text] [Related]
9. Randomized Trial of Vitamin D Supplementation to Prevent Seasonal Influenza and Upper Respiratory Infection in Patients With Inflammatory Bowel Disease.
Arihiro S; Nakashima A; Matsuoka M; Suto S; Uchiyama K; Kato T; Mitobe J; Komoike N; Itagaki M; Miyakawa Y; Koido S; Hokari A; Saruta M; Tajiri H; Matsuura T; Urashima M
Inflamm Bowel Dis; 2019 May; 25(6):1088-1095. PubMed ID: 30601999
[TBL] [Abstract][Full Text] [Related]
10. Zingiber officinale and oxidative stress in patients with ulcerative colitis: A randomized, placebo-controlled, clinical trial.
Nikkhah-Bodaghi M; Maleki I; Agah S; Hekmatdoost A
Complement Ther Med; 2019 Apr; 43():1-6. PubMed ID: 30935515
[TBL] [Abstract][Full Text] [Related]
11. The effects of Nigella sativa on quality of life, disease activity index, and some of inflammatory and oxidative stress factors in patients with ulcerative colitis.
Nikkhah-Bodaghi M; Darabi Z; Agah S; Hekmatdoost A
Phytother Res; 2019 Apr; 33(4):1027-1032. PubMed ID: 30666747
[TBL] [Abstract][Full Text] [Related]
12. A randomized clinical trial of vitamin D
Mathur J; Naing S; Mills P; Limsui D
PeerJ; 2017; 5():e3654. PubMed ID: 28791200
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D Decreases Beck Depression Inventory Score in Patients with Mild to Moderate Ulcerative Colitis: A Double-Blind Randomized Placebo-Controlled Trial.
Sharifi A; Vahedi H; Nedjat S; Mohamadkhani A; Hosseinzadeh Attar MJ
J Diet Suppl; 2019; 16(5):541-549. PubMed ID: 29958055
[TBL] [Abstract][Full Text] [Related]
14. Does serum 25 hydroxy vitamin D level predict disease activity in ulcerative colitis patients?
Dolatshahi S; Pishgar E; Jamali R
Acta Clin Belg; 2016 Feb; 71(1):46-50. PubMed ID: 27075790
[TBL] [Abstract][Full Text] [Related]
15. Effects of saffron supplementation on oxidative/antioxidant status and severity of disease in ulcerative colitis patients: A randomized, double-blind, placebo-controlled study.
Tahvilian N; Masoodi M; Faghihi Kashani A; Vafa M; Aryaeian N; Heydarian A; Hosseini A; Moradi N; Farsi F
Phytother Res; 2021 Feb; 35(2):946-953. PubMed ID: 33015869
[TBL] [Abstract][Full Text] [Related]
16. LOWER LEVELS OF VITAMIN D CORRELATE WITH CLINICAL DISEASE ACTIVITY AND QUALITY OF LIFE IN INFLAMMATORY BOWEL DISEASE.
Castro FD; Magalhães J; Carvalho PB; Moreira MJ; Mota P; Cotter J
Arq Gastroenterol; 2015 Dec; 52(4):260-5. PubMed ID: 26840465
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D and Ulcerative Colitis: Is There a Relationship with Disease Extent?
Chetcuti Zammit S; Schembri J; Pisani A; Vella S; Azzopardi M; Skamnelos A; Christodoulou DK; Katsanos KH; Ellul P
Dig Dis; 2019; 37(3):208-213. PubMed ID: 30384373
[TBL] [Abstract][Full Text] [Related]
18. The effect of selenium supplementation on disease activity and immune-inflammatory biomarkers in patients with mild-to-moderate ulcerative colitis: a randomized, double-blind, placebo-controlled clinical trial.
Khazdouz M; Daryani NE; Cheraghpour M; Alborzi F; Hasani M; Ghavami SB; Shidfar F
Eur J Nutr; 2023 Dec; 62(8):3125-3134. PubMed ID: 37525068
[TBL] [Abstract][Full Text] [Related]
19. Vitamin A supplementation decreases disease activity index in patients with ulcerative colitis: A randomized controlled clinical trial.
Masnadi Shirazi K; Nikniaz Z; Masnadi Shirazi A; Rohani M
Complement Ther Med; 2018 Dec; 41():215-219. PubMed ID: 30477842
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of High-dose Cholecalciferol in Patients With Inflammatory Bowel Disease Receiving Infliximab.
Gordon RJ; Wells R; Johansen C; Liu S; Dahlberg SE; Snapper SB; Rufo PA
J Pediatr Gastroenterol Nutr; 2022 Apr; 74(4):476-483. PubMed ID: 35045559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
